Posted by Jim Marino on December 2, 2009
Ekkyo(TM), a photomedicine company that develops first-in-class laser-based systems for skin scar prevention and reduction is presented its assessment one year after the commercial launch of EkkyLite(TM). Ekkyo has also set up a national register to log and measure the development of the healing process for each patient treated. This confidential register provides personalised access for each practitioner equipped with an EkkyLite (TM) system.
Posted by Jim Marino on November 25, 2009
American Biotech Labs has announced that it has obtained clearance by the FDA to market its ASAP Antibacterial Silver Wound Dressing Gel as a prescription 510(k) medical device throughout the United States. The FDA 510(k) medical device clearance enables ABL to market its ASAP Antibacterial Silver Gel “for use in the management of 1st and 2nd degree burns, stasis ulcers, pressure ulcers, diabetic ulcers, lacerations, abrasions, skin tears and surgical incision sites.
Posted by Jim Marino on November 18, 2009
Fresenius Medical Care has launched a new therapy program for peritoneal dialysis (PD). ‘P3′, the first comprehensive PD care concept of its kind. In contrast to the mere provision of individual products and services, ‘P3′ for the first time provides PD therapy as an integrated care program, incorporating all aspects of treatment, from the PD machine, or “cycler”, and related equipment to special software and services for the monitoring of treatment safety and quality
Posted by Jim Marino on November 11, 2009
APP Pharmaceuticals, Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market Chlorothiazide Sodium for Injection, USP. Chlorothiazide Sodium for Injection, USP is therapeutically equivalent to the reference-listed drug Diuril®, which is marketed by Lundbeck Pharmaceuticals. Chlorothiazide is a diuretic used to treat high blood pressure, and fluid retention in people with congestive heart failure, cirrhosis of the liver and kidney disorders.
Posted by Jim Marino on November 4, 2009
3M Health Care the innovative technology company haslaunched the first Antimicrobial Tegaderm CHG IV Transparent Securement Dressing at the 2009 Patient Safety Congress, Abu Dhabi. The dressing integrates the powerful antimicrobial action of Chlorhexidine Gluconate (CHG) with the high performance of a Tegaderm dressing, and has been designed to reduce skin flora – the most common cause of catheter-related bloodstream infection (CR-BSI), which can prolong hospital stays by an average of 20 days.
Posted by Jim Marino on October 28, 2009
HealthStat International has launched a portable home device A-Pulse CASPal to measure blood pressure from a person’s aorta. This reading is a better indicator of the risk of heart attacks and strokes than one taken the conventional way from the arm. The device offers a non-invasive way of getting a reading of the blood pressure from the aorta, the main vessel which carries oxygenated blood out of the heart to the rest of the body.
Posted by Jim Marino on October 21, 2009
Nano Mask Inc has retained AlvaMed LLC, an FDA consulting firm specializing in medical devices, to prepare the company’s latest generation disposable, anti-viral NanoMask for FDA approval. Doug Heath, CEO of Nano Mask, has indicated that the company is looking forward to working with AlvaMed’s team in obtaining the FDA approval in a timely manner.
Posted by Jim Marino on October 14, 2009
BD Diagnostics – Preanalytical Systems, a unit of BD (Becton, Dickinson and Company), has received the FDA 510(k) clearance for the BD Vacutainer® Rapid Serum Tube. BD Vacutainer is a blood collection device designed to help acute healthcare facilities rapidly analyze blood serum for patient diagnosis. Technologies such as the BD Vacutainer Rapid Serum Tube can help reduce the time it takes to get answers from blood tests and have a significant impact on patient care and hospital productivity.”
Posted by Jim Marino on October 6, 2009
The NT-V2 Advanced Technology Respirator Face Mask is now available through BeyondN95Mask.com, a division of Spartan Business Services LLC. The NT-V2 Mask is the next step beyond N95 Respirator Masks. This unique NIOSH approved N95 respirator utilizes Nano Technology to help neutralize airborne germs, such as those which cause Swine Flu (H1N1), Bird Flu (H5N1), Anthrax, Tuberculosis, and MRSA. It is the world’s first self-sterilizing mask, manufactured by one of only two companies in the world with an FDA approved N95 mask.
Posted by Jim Marino on September 30, 2009
The FDA is advising consumers not to use certain respiratory medications made by Canonsburg-based Mylan Inc. The FDA says the medications may have been the part of a shipment being transported on a tractor-trailer that was stolen in Tampa, Florida, on September 8, 2009. The alert involves the Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution. People who use the medications should check to see if they have any products that were received or purchased after September 8 and return them to the pharmacy where they were bought.
« Previous Page — Next Page »